News from cormedix inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Dec 04, 2014, 09:22 ET
CorMedix Logo

CorMedix Inc. Files Request with FDA for QIDP Designation for Neutrolin®

 CorMedix Inc. (NYSE MKT: CRMD), a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and...

Dec 03, 2014, 14:09 ET

Neutrolin Label Expansion Approved in Germany

CorMedix Inc. (NYSE MKT: CRMD), a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and...

Nov 06, 2014, 16:08 ET
CorMedix Logo.

CorMedix, Inc. to Announce Third Quarter 2014 Results on November 13, 2014; Conference call hosted at 9 am on Friday, November 14, 2014

CorMedix Inc. ("CorMedix") (NYSE MKT: CRMD), a specialty pharmaceutical company focused on developing and commercializing therapeutic products for...

Sep 25, 2014, 08:00 ET

CorMedix Announces FDA IND Filing for Neutrolin® in United States

CorMedix Inc. (NYSE MKT: CRMD), a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and...

Sep 22, 2014, 08:00 ET

Neutrolin Label Expansion Approved for the European Union

 CorMedix Inc. (NYSE MKT: CRMD), a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and...

Sep 16, 2014, 08:00 ET

CorMedix Amends and Restates Outstanding Securities to Remove Provisions Causing Derivative Liability Classification

CorMedix Inc. ("CorMedix") (NYSE MKT: CRMD), a pharmaceutical company focused on developing and commercializing therapeutic products for the...

Aug 14, 2014, 16:45 ET

FDA Accepts CorMedix, Inc. Pivotal Phase 3 Study Protocol

 CorMedix Inc. (NYSE MKT: CRMD), a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and...

Jul 24, 2014, 12:30 ET

CorMedix, Inc. Granted Extension of NYSE-MKT Listing

 CorMedix Inc. (NYSE MKT: CRMD), a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and...

Jun 23, 2014, 16:15 ET
CorMedix Logo.  (PRNewsFoto/CorMedix Inc.)

CorMedix, Inc. Finalizes Pivotal Phase 3 Study Protocol for FDA

 CorMedix Inc. (NYSE MKT: CRMD), a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and...

May 23, 2014, 16:15 ET
CorMedix Logo.  (PRNewsFoto/CorMedix Inc.)

CorMedix Notified of NYSE MKT Listing Deficiency

 CorMedix Inc. ("CorMedix") (NYSE MKT: CRMD), a pharmaceutical company focused on developing and commercializing therapeutic products for the...

May 13, 2014, 17:26 ET
CorMedix Logo.  (PRNewsFoto/CorMedix Inc.)

CorMedix Inc. to Announce First Quarter 2014 Results on May 15, 2014

CorMedix Inc. ("CorMedix") (NYSE MKT: CRMD), a specialty pharmaceutical company focused on developing and commercializing therapeutic...

Apr 07, 2014, 08:30 ET
CorMedix Logo.  (PRNewsFoto/CorMedix Inc.)

CorMedix Inc. Welcomes Additional Board Members

 CorMedix Inc. (NYSE MKT: CRMD), a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and...

Mar 27, 2014, 18:39 ET
CorMedix Logo.  (PRNewsFoto/CorMedix Inc.)

CorMedix Inc. to Report 2013 Year End Results on March 31, 2014, and Host Conference Call at 9 am on April 1, 2014

CorMedix Inc. ("CorMedix") (NYSE MKT: CRMD), a specialty pharmaceutical company focused on developing and commercializing therapeutic products for...

Mar 10, 2014, 16:05 ET
CorMedix Logo.  (PRNewsFoto/CorMedix Inc.)

CorMedix Inc. Announces Close of Registered Direct Offering

CorMedix Inc. (NYSE MKT: CRMD), a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and...

Mar 04, 2014, 21:50 ET
CorMedix Logo.  (PRNewsFoto/CorMedix Inc.)

CorMedix Inc. Announces Registered Direct Offering

CorMedix Inc. (NYSE MKT: CRMD), a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and...

Jan 13, 2014, 08:30 ET
CorMedix Logo.  (PRNewsFoto/CorMedix Inc.)

CorMedix Expands Neutrolin® Sales with Middle East Distribution Agreements

 CorMedix Inc. (NYSE MKT: CRMD), a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention...

Jan 10, 2014, 08:32 ET
CorMedix Logo.  (PRNewsFoto/CorMedix Inc.)

CorMedix Awarded European Patent for Neutrolin

 CorMedix Inc. (NYSE MKT: CRMD), a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention...

Jan 08, 2014, 09:16 ET
CorMedix Logo.  (PRNewsFoto/CorMedix Inc.)

CorMedix Inc. to Raise $2,000,000 in Follow On Offering

- CorMedix Inc. (NYSE MKT: CRMD), a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and...

Dec 23, 2013, 09:51 ET
CorMedix Logo.  (PRNewsFoto/CorMedix Inc.)

CorMedix Receives Minutes from Neutrolin Pre-IND Meeting with FDA

CorMedix Inc. (NYSE MKT: CRMD), a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and...

Dec 12, 2013, 11:14 ET
CorMedix Logo.  (PRNewsFoto/CorMedix Inc.)

CorMedix Announces First Sales of Neutrolin® in the European Union

 CorMedix Inc. (NYSE MKT: CRMD), a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention...